Transforming diagnostics for better patient care
30 Sept 2024
With clinical data growing and diagnostic speed increasing, there's still room for improvement. By harnessing advanced tools, AI, and new technologies, we can unlock unseen data and provide even faster, more accurate patient care. Beckman Coulter is leading the charge, using decades of experience to develop biomarker solutions, drive personalized treatments, and bridge the gap between labs and patients. Together, we can reimagine healthcare, one diagnosis at a time, for the best possible care.
About the company

Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.




















